Clinical trial
A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol…
NCT00063102 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00063102 |
|---|---|
| Title | A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy. |
| Official title | A Phase II Study of ABT-751 in Patients With Breast Cancer Refractory to Taxane Regimens |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | ABT-751 |
| Enrollment | 40 |
| Start date | Nov 1, 2002 |
| Completion | Aug 1, 2004 |
| First posted | Jun 23, 2003 |
| Last update posted | Nov 29, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: